Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 16. doi: 10.1056/NEJMoa1907863. [Epub ahead of print]

PMID:
31618560
2.

Identity and Treatment Adherence in Predominantly Ethnic Minority Teens and Young Adults with Type 1 Diabetes.

Commissariat PV, Laffel LM, Gonzalez JS.

Pediatr Diabetes. 2019 Oct 11. doi: 10.1111/pedi.12932. [Epub ahead of print]

PMID:
31603620
3.

Advances in technology for management of type 1 diabetes.

Beck RW, Bergenstal RM, Laffel LM, Pickup JC.

Lancet. 2019 Oct 5;394(10205):1265-1273. doi: 10.1016/S0140-6736(19)31142-0. Epub 2019 Sep 15. Review.

PMID:
31533908
4.

A mobile app identifies momentary psychosocial and contextual factors related to mealtime self-management in adolescents with type 1 diabetes.

Mulvaney SA, Vaala SE, Carroll RB, Williams LK, Lybarger CK, Schmidt DC, Dietrich MS, Laffel LM, Hood KK.

J Am Med Inform Assoc. 2019 Sep 16. pii: ocz147. doi: 10.1093/jamia/ocz147. [Epub ahead of print]

PMID:
31529065
5.

Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial.

Bacha F, El Ghormli L, Arslanian S, Zeitler P, Laffel LM, Levitt Katz LE, Gandica R, Chang NT, Sprague JE, Macleish SA; TODAY Study Group.

Pediatr Diabetes. 2019 Nov;20(7):871-879. doi: 10.1111/pedi.12906. Epub 2019 Aug 27.

PMID:
31418516
6.

"Let's talk about it" The role of parental communication in adolescents' motivation to adhere to treatment recommendations for type 1 diabetes.

Goethals ER, Soenens B, de Wit M, Vansteenkiste M, Laffel LM, Casteels K, Luyckx K.

Pediatr Diabetes. 2019 Nov;20(7):1025-1034. doi: 10.1111/pedi.12901. Epub 2019 Aug 16.

PMID:
31369191
7.

Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.

Zhu J, Volkening LK, Laffel LM.

Diabetes Care. 2019 Jul 15. pii: dc190083. doi: 10.2337/dc19-0083. [Epub ahead of print]

PMID:
31308020
8.

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA.

Diabet Med. 2019 Nov;36(11):1508-1510. doi: 10.1111/dme.14074. Epub 2019 Jul 25. No abstract available.

PMID:
31295359
9.

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA.

Diabetes Technol Ther. 2019 Sep;21(9):493-498. doi: 10.1089/dia.2019.0142. Epub 2019 Jul 9.

PMID:
31287721
10.

Autism spectrum disorder in children with Type 1 diabetes.

Bethin KE, Kanapka LG, Laffel LM, Majidi S, Chaytor NS, MacLeish S, Adams R, Foster NC; T1D Exchange Clinic Network.

Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14069. [Epub ahead of print]

PMID:
31271682
11.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

12.

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

Perkins BA, Rosenstock J, Skyler JS, Laffel LM, Cherney DZ, Mathieu C, Pang C, Wood R, Kinduryte O, George JT, Marquard J, Soleymanlou N.

Diabetes Care. 2019 Sep;42(9):1716-1723. doi: 10.2337/dc19-0548. Epub 2019 Jun 8.

PMID:
31177179
13.

Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience.

Songer TJ, Haymond MW, Glazner JE, Klingensmith GJ, Laffel LM, Zhang P, Hirst K; TODAY Study Group.

Pediatr Diabetes. 2019 Sep;20(6):702-711. doi: 10.1111/pedi.12869. Epub 2019 Jun 6.

14.

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.

Bode BW, Iotova V, Kovarenko M, Laffel LM, Rao PV, Deenadayalan S, Ekelund M, Larsen SF, Danne T.

Diabetes Care. 2019 Jul;42(7):1255-1262. doi: 10.2337/dc19-0009. Epub 2019 May 10.

PMID:
31076415
15.

Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ; TODAY Study Group.

Diabetes Care. 2019 Jun;42(6):1120-1128. doi: 10.2337/dc18-2147. Epub 2019 Apr 9.

PMID:
30967435
16.

Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.

Weinstock RS, Braffett BH, McGuigan P, Larkin ME, Grover NB, Walders-Abramson N, Laffel LM, Chan CL, Chang N, Schwartzman BE, Barajas RA, Celona-Jacobs N, Haymond MW; TODAY Study Group.

Diabetes Care. 2019 May;42(5):903-909. doi: 10.2337/dc18-1854. Epub 2019 Mar 4.

PMID:
30833375
17.

Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.

Weissberg-Benchell J, Shapiro JB, Hood K, Laffel LM, Naranjo D, Miller K, Barnard K.

Diabet Med. 2019 May;36(5):644-652. doi: 10.1111/dme.13930. Epub 2019 Mar 20.

18.

Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes.

McGill DE, Volkening LK, Butler DA, Wasserman RM, Anderson BJ, Laffel LM.

Diabet Med. 2019 May;36(5):600-605. doi: 10.1111/dme.13929. Epub 2019 Feb 25.

PMID:
30734361
19.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

PMID:
30649925
20.

Factors associated with disordered eating behaviours in adolescents with Type 1 diabetes.

Cecilia-Costa R, Volkening LK, Laffel LM.

Diabet Med. 2019 Aug;36(8):1020-1027. doi: 10.1111/dme.13890. Epub 2019 Mar 4.

PMID:
30582670
21.

Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories.

Zhu J, Volkening LK, Laffel LM.

J Clin Endocrinol Metab. 2019 Jan 1;104(1):74-82. doi: 10.1210/jc.2018-01737.

PMID:
30346541
22.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
23.

Management of cardiovascular disease risk in teens with type 1 diabetes: Perspectives of teens with and without dyslipidemia and parents.

Katz ML, Guo Z, Cheema A, Laffel LM.

Pediatr Diabetes. 2019 Mar;20(2):210-216. doi: 10.1111/pedi.12771.

PMID:
30209870
24.

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.

Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D.

Diabetes Care. 2018 Sep;41(9):2026-2044. doi: 10.2337/dci18-0023. Epub 2018 Aug 9. No abstract available.

25.

ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes.

Laffel LM, Limbert C, Phelan H, Virmani A, Wood J, Hofer SE.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:193-204. doi: 10.1111/pedi.12741. No abstract available.

PMID:
30079506
26.

Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet: A Word of Caution.

Mayer-Davis EJ, Laffel LM, Buse JB.

Pediatrics. 2018 Aug;142(2). pii: e20181536B. doi: 10.1542/peds.2018-1536B. No abstract available.

27.

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.

Bjornstad P, Laffel L, Tamborlane WV, Simons G, Hantel S, von Eynatten M, George J, Marquard J, Cherney DZI.

Diabetes Care. 2018 Aug;41(8):e129-e130. doi: 10.2337/dc18-0394. Epub 2018 Jun 25. No abstract available.

28.

Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.

Shah VN, Laffel LM, Wadwa RP, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):428-433. doi: 10.1089/dia.2018.0143.

29.

Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.

Wadwa RP, Laffel LM, Shah VN, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):395-402. doi: 10.1089/dia.2018.0150. Epub 2018 Jun 14.

30.

Transitions in Care from Pediatric to Adult Health Care Providers: Ongoing Challenges and Opportunities for Young Persons with Diabetes.

Garvey K, Laffel L.

Endocr Dev. 2018;33:68-81. doi: 10.1159/000487866. Epub 2018 Jun 8.

PMID:
29886494
31.

Mobile Momentary Assessment and Biobehavioral Feedback for Adolescents with Type 1 Diabetes: Feasibility and Engagement Patterns.

Mulvaney SA, Vaala S, Hood KK, Lybarger C, Carroll R, Williams L, Schmidt DC, Johnson K, Dietrich MS, Laffel L.

Diabetes Technol Ther. 2018 Jul;20(7):465-474. doi: 10.1089/dia.2018.0064. Epub 2018 Jun 8.

32.

Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Teló GH, Dougher CE, Volkening LK, Katz ML, Laffel LM.

Diabet Med. 2018 Oct;35(10):1355-1363. doi: 10.1111/dme.13699. Epub 2018 Jun 19.

33.

Lost in transition: finding a path forward for young adults with Type 1 diabetes.

Laffel L.

Diabet Med. 2018 Aug;35(8):1061-1062. doi: 10.1111/dme.13684. Epub 2018 Jul 5. No abstract available.

PMID:
29790218
34.

Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.

McGill DE, Volkening LK, Butler DA, Harrington KR, Katz ML, Laffel LM.

Diabetes Technol Ther. 2018 Jun;20(6):434-439. doi: 10.1089/dia.2018.0037. Epub 2018 May 4.

35.

Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.

Laffel LMB, Tamborlane WV, Yver A, Simons G, Wu J, Nock V, Hobson D, Hughan KS, Kaspers S, Marquard J.

Diabet Med. 2018 Aug;35(8):1096-1104. doi: 10.1111/dme.13629. Epub 2018 May 6.

36.

Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Garza KP, Jedraszko A, Weil LEG, Naranjo D, Barnard KD, Laffel LMB, Hood KK, Weissberg-Benchell J.

Diabetes Technol Ther. 2018 Mar;20(3):222-228. doi: 10.1089/dia.2017.0301.

37.

Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.

Inge TH, Laffel LM, Jenkins TM, Marcus MD, Leibel NI, Brandt ML, Haymond M, Urbina EM, Dolan LM, Zeitler PS; Teen–Longitudinal Assessment of Bariatric Surgery (Teen-LABS) and Treatment Options of Type 2 Diabetes in Adolescents and Youth (TODAY) Consortia.

JAMA Pediatr. 2018 May 1;172(5):452-460. doi: 10.1001/jamapediatrics.2017.5763.

38.

Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes.

Venditti EM, Tan K, Chang N, Laffel L, McGinley G, Miranda N, Tryggestad JB, Walders-Abramson N, Yasuda P, Delahanty L; TODAY Study Group.

Diabetes Res Clin Pract. 2018 May;139:24-31. doi: 10.1016/j.diabres.2018.02.001. Epub 2018 Feb 8.

39.

Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.

Katz ML, Guo Z, Laffel LM.

J Pediatr. 2018 Jun;197:140-146.e12. doi: 10.1016/j.jpeds.2017.11.059. Epub 2018 Feb 1.

40.

Disordered Eating Behaviors Are Not Increased by an Intervention to Improve Diet Quality but Are Associated With Poorer Glycemic Control Among Youth With Type 1 Diabetes.

Eisenberg Colman MH, Quick VM, Lipsky LM, Dempster KW, Liu A, Laffel LMB, Mehta SN, Nansel TR.

Diabetes Care. 2018 Apr;41(4):869-875. doi: 10.2337/dc17-0090. Epub 2018 Jan 25.

41.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 1.

42.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

43.

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002-1009.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2018 Mar;41(3):640. doi: 10.2337/dc18-er03. Epub 2018 Jan 10. No abstract available.

44.

Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation.

McGill DE, Volkening LK, Pober DM, Muir AB, Young-Hyman DL, Laffel LM.

J Adolesc Health. 2018 Feb;62(2):219-225. doi: 10.1016/j.jadohealth.2017.09.017. Epub 2017 Dec 6.

45.

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.

Tamborlane WV, Laffel LM, Weill J, Gordat M, Neubacher D, Retlich S, Hettema W, Hoesl CE, Kaspers S, Marquard J.

Pediatr Diabetes. 2018 Jun;19(4):640-648. doi: 10.1111/pedi.12616. Epub 2017 Nov 24.

PMID:
29171139
46.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

47.

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.

Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ; TODAY Study Group.

Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20. Erratum in: Am J Kidney Dis. 2019 Apr;73(4):580.

48.

What End Users and Stakeholders Want From Automated Insulin Delivery Systems.

Naranjo D, Suttiratana SC, Iturralde E, Barnard KD, Weissberg-Benchell J, Laffel L, Hood KK.

Diabetes Care. 2017 Nov;40(11):1453-1461. doi: 10.2337/dc17-0400. Epub 2017 Aug 25.

49.

Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes.

Harrington KR, Boyle CT, Miller KM, Hilliard ME, Anderson BJ, Van Name M, DiMeglio LA, Laffel LM; T1D Exchange Clinic Network.

J Diabetes Sci Technol. 2017 Sep;11(5):980-987. doi: 10.1177/1932296817721938. Epub 2017 Aug 3.

50.

Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial.

Berkowitz RI, Marcus MD, Anderson BJ, Delahanty L, Grover N, Kriska A, Laffel L, Syme A, Venditti E, Van Buren DJ, Wilfley DE, Yasuda P, Hirst K; TODAY Study Group.

Pediatr Diabetes. 2018 Mar;19(2):191-198. doi: 10.1111/pedi.12555. Epub 2017 Jun 30.

Supplemental Content

Loading ...
Support Center